Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Quarterly Sales
Pharma
Roche's juggernaut Vabysmo rout analyst consensus
In the first quarter, Roche's Vabysmo racked up sales of 847M Swiss francs, which was up 108% and demolished analysts' consensus.
Kevin Dunleavy
Apr 24, 2024 11:29am
J&J reports $133M in sales for new multiple myeloma med Tecvayli
Apr 16, 2024 11:28am
Bluebird discusses Lyfgenia launch details and accounting errors
Mar 26, 2024 10:49am
Despite solid pharma growth, Merck KGaA sees total sales decline
Mar 7, 2024 3:32pm
Apellis working through continued challenges with Syfovre launch
Feb 28, 2024 11:53am
Novo Nordisk, Eli Lilly lead industrywide sales surge in Q4
Feb 22, 2024 3:20pm